Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate

@article{Watts2001ComparisonOB,
  title={Comparison of Bone and Total Alkaline Phosphatase and Bone Mineral Density in Postmenopausal Osteoporotic Women Treated with Alendronate},
  author={Nelson B. Watts and D. Kenneth Jenkins and J. M. Visor and David C. Casal and Piet P. Geusens},
  journal={Osteoporosis International},
  year={2001},
  volume={12},
  pages={279-288}
}
Alendronate therapy in osteoporotic women decreases bone turnover and increases bone mineral density (BMD). Optimal patient management should include verification that each patient is responding to therapy. Markers of bone turnover and BMD have both been proposed for this purpose. We have investigated changes resulting from alendronate therapy with an… CONTINUE READING